Novel Drug Delivery Systems Global Market Report 2025

Description

Novel drug delivery systems are advanced pharmaceutical technologies aimed at improving the effectiveness, safety, bioavailability, and targeted delivery of medications by precisely controlling the rate, timing, and location of drug release in the body. These systems address the shortcomings of traditional delivery methods, enhance treatment outcomes, and boost patient adherence across diverse medical and therapeutic fields.

Key formulation types within novel drug delivery systems include liposomes, nanoparticles, microspheres, hydrogels, and dendrimers. Liposomes are spherical vesicles made of phospholipid bilayers that encapsulate drugs, allowing for targeted delivery, controlled release, and minimized drug toxicity. The delivery modes include targeted, controlled, and modulated drug delivery systems, which are administered through various routes such as oral, injectable, pulmonary, transdermal, and others. These systems are applied in multiple therapeutic areas including cancer, cardiovascular diseases, neurological disorders, infectious diseases, and autoimmune diseases, serving end-users like hospitals, specialty clinics, research centers, and more.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The novel drug delivery systems market research report is one of a series of new reports from The Business Research Company that provides novel drug delivery systems market statistics, including novel drug delivery systems industry global market size, regional shares, competitors with a novel drug delivery systems market share, detailed novel drug delivery systems market segments, market trends and opportunities, and any further data you may need to thrive in the novel drug delivery systems industry. This novel drug delivery systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The novel drug delivery systems market size has grown rapidly in recent years. It will grow from $106.95 billion in 2024 to $117.66 billion in 2025 at a compound annual growth rate (CAGR) of 10.0%. The growth during the historic period can be linked to the increasing prevalence of chronic diseases, an expanding geriatric population, rising demand for minimally invasive treatments, heightened patient awareness about drug efficacy and safety, and the development of global healthcare infrastructure.

The novel drug delivery systems market size is expected to see strong growth in the next few years. It will grow to $171.02 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%. The growth projected for the forecast period can be attributed to a heightened global emphasis on pandemic preparedness, increased demand for rapid and targeted drug delivery, greater awareness of antimicrobial stewardship, stricter environmental and packaging regulations favoring controlled delivery methods, and expanding public-private partnerships in pharmaceutical innovation. Key trends during this period include the incorporation of nanocarriers and nanoemulsions, development of biodegradable and stimuli-responsive materials, wider use of 3D printing for personalized dosage forms, advancements in transdermal and microneedle technologies, and the adoption of artificial intelligence in formulation design.

The increasing cases of neurological disorders are anticipated to drive growth in the novel drug delivery systems market. Neurological disorders like stroke involve the sudden loss of neurological function caused by interrupted blood flow to the brain, either through a blockage (ischemic stroke) or a blood vessel rupture (hemorrhagic stroke), resulting in brain damage and possible long-term impairments in cognition, sensation, or movement. Factors such as aging populations, the rising prevalence of lifestyle-related conditions including hypertension, diabetes, and obesity, as well as greater exposure to chronic stress and environmental risks, are contributing to the increase in neurological disorders. Novel drug delivery systems aid in treating these disorders by providing targeted and controlled delivery of medications across the blood-brain barrier. For example, in November 2024, the National Health Service (NHS) England reported that stroke admissions in England reached 111,137 in 2023/24, with the highest rise seen in the 50-59 age group, which had 12,533 new cases. Consequently, the growing incidence of neurological disorders is fueling the novel drug delivery systems market.

Leading companies in the novel drug delivery systems market are innovating with products like oral thin films to improve patient compliance and treatment effectiveness. Oral thin films are rapidly dissolving strips applied inside the mouth that deliver drugs directly into the bloodstream through the mucosal lining. For example, in February 2024, CD Formulation, a US pharmaceutical formulation company, introduced Oral Thin Film Technology. This technology enables quick drug absorption by bypassing the gastrointestinal tract and liver metabolism, making it ideal for patients who have difficulty swallowing. It also allows precise dosing and faster onset of effects, enhancing treatment accuracy and convenience across multiple therapies.

In April 2023, DifGen Pharmaceuticals LLC, a US-based pharmaceutical firm, acquired Aveva Drug Delivery Services Inc. for an undisclosed sum. This acquisition is intended to expand DifGen's expertise in complex dosage forms by adding US research and manufacturing capabilities for transdermal and thin film drug delivery systems. Aveva Drug Delivery Services Inc. specializes in transdermal drug delivery and oral dissolvable films.

Major players in the novel drug delivery systems market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, Thermo Fisher Scientific Company, AstraZeneca PLC, Abbott Laboratories, Novartis AG, GlaxoSmithKline PLC (GSK), Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences, Amgen Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Boston Scientific Corporation, Regeneron Pharmaceuticals, Samyang Holdings Corporation, and Galen Limited.

North America was the largest region in the novel drug delivery systems market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in novel drug delivery systems report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the novel drug delivery systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The novel drug delivery systems market consists of sales of implants, micelles, exosomes, prodrugs, nasal drug delivery devices, buccal drug delivery films, and ocular drug delivery inserts. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Novel Drug Delivery Systems Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on novel drug delivery systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for novel drug delivery systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The novel drug delivery systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Formulation Type: Liposomes; Nanoparticles; Microspheres; Hydrogels; Dendrimers
2) By Mode Of Novel Drug Delivery System (NDDS): Targeted Drug Delivery Systems; Controlled Drug Delivery Systems; Modulated Drug Delivery Systems
3) By Route: Oral Drug Delivery Systems; Injectable Drug Delivery Systems; Pulmonary Drug Delivery Systems; Transdermal Drug Delivery Systems; Other Routes
4) By Therapeutic Area: Cancer; Cardiovascular Diseases; Neurological Disorders; Infectious Diseases; Autoimmune Diseases
5) By End-User: Hospital; Specialty Clinics; Research Centers; Other End-Users
Subsegments:
1) By Liposomes: PEGylated Liposomes; Cationic Liposomes; Stealth Liposomes; Immunoliposomes
2) By Nanoparticles: Polymeric Nanoparticles; Lipid Nanoparticles; Metallic Nanoparticles; Nanocrystals
3) By Microspheres: Biodegradable Microspheres; Magnetic Microspheres; Radioactive Microspheres; Mucoadhesive Microspheres
4) By Hydrogels: Thermosensitive Hydrogels; Ph-Responsive Hydrogels; Injectable Hydrogels; Smart Hydrogels
5) By Dendrimers: PAMAM Dendrimers; PPI Dendrimers; Pegylated Dendrimers; Hybrid Dendrimers
Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche AG; Merck & Co. Inc.; AbbVie Inc.; Bayer AG; Sanofi SA; Bristol-Myers Squibb Company; Thermo Fisher Scientific Company; AstraZeneca PLC; Abbott Laboratories; Novartis AG; GlaxoSmithKline PLC (GSK); Takeda Pharmaceutical Company Limited; Eli Lilly and Company; Gilead Sciences; Amgen Inc.; Teva Pharmaceutical Industries Ltd.; Otsuka Pharmaceutical Co. Ltd.; Boston Scientific Corporation; Regeneron Pharmaceuticals; Samyang Holdings Corporation; Galen Limited.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r37079

1. Executive Summary

2. Novel Drug Delivery Systems Market Characteristics

3. Novel Drug Delivery Systems Market Trends And Strategies

4. Novel Drug Delivery Systems Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Novel Drug Delivery Systems Growth Analysis And Strategic Analysis Framework

5.1. Global Novel Drug Delivery Systems PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Novel Drug Delivery Systems Market Growth Rate Analysis
5.4. Global Novel Drug Delivery Systems Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Novel Drug Delivery Systems Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Novel Drug Delivery Systems Total Addressable Market (TAM)

6. Novel Drug Delivery Systems Market Segmentation

6.1. Global Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Liposomes
Nanoparticles
Microspheres
Hydrogels
Dendrimers
6.2. Global Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Targeted Drug Delivery Systems
Controlled Drug Delivery Systems
Modulated Drug Delivery Systems
6.3. Global Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Drug Delivery Systems
Injectable Drug Delivery Systems
Pulmonary Drug Delivery Systems
Transdermal Drug Delivery Systems
Other Routes
6.4. Global Novel Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cancer
Cardiovascular Diseases
Neurological Disorders
Infectious Diseases
Autoimmune Diseases
6.5. Global Novel Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital
Specialty Clinics
Research Centers
Other End-Users
6.6. Global Novel Drug Delivery Systems Market, Sub-Segmentation Of Liposomes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
PEGylated Liposomes
Cationic Liposomes
Stealth Liposomes
Immunoliposomes
6.7. Global Novel Drug Delivery Systems Market, Sub-Segmentation Of Nanoparticles, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Polymeric Nanoparticles
Lipid Nanoparticles
Metallic Nanoparticles
Nanocrystals
6.8. Global Novel Drug Delivery Systems Market, Sub-Segmentation Of Microspheres, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Biodegradable Microspheres
Magnetic Microspheres
Radioactive Microspheres
Mucoadhesive Microspheres
6.9. Global Novel Drug Delivery Systems Market, Sub-Segmentation Of Hydrogels, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Thermosensitive Hydrogels
Ph-Responsive Hydrogels
Injectable Hydrogels
Smart Hydrogels
6.10. Global Novel Drug Delivery Systems Market, Sub-Segmentation Of Dendrimers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
PAMAM Dendrimers
PPI Dendrimers
Pegylated Dendrimers
Hybrid Dendrimers

7. Novel Drug Delivery Systems Market Regional And Country Analysis

7.1. Global Novel Drug Delivery Systems Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Novel Drug Delivery Systems Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Novel Drug Delivery Systems Market

8.1. Asia-Pacific Novel Drug Delivery Systems Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Novel Drug Delivery Systems Market

9.1. China Novel Drug Delivery Systems Market Overview
9.2. China Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Novel Drug Delivery Systems Market

10.1. India Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Novel Drug Delivery Systems Market

11.1. Japan Novel Drug Delivery Systems Market Overview
11.2. Japan Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Novel Drug Delivery Systems Market

12.1. Australia Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Novel Drug Delivery Systems Market

13.1. Indonesia Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Novel Drug Delivery Systems Market

14.1. South Korea Novel Drug Delivery Systems Market Overview
14.2. South Korea Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Novel Drug Delivery Systems Market

15.1. Western Europe Novel Drug Delivery Systems Market Overview
15.2. Western Europe Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Novel Drug Delivery Systems Market

16.1. UK Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Novel Drug Delivery Systems Market

17.1. Germany Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Novel Drug Delivery Systems Market

18.1. France Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Novel Drug Delivery Systems Market

19.1. Italy Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Novel Drug Delivery Systems Market

20.1. Spain Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Novel Drug Delivery Systems Market

21.1. Eastern Europe Novel Drug Delivery Systems Market Overview
21.2. Eastern Europe Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Novel Drug Delivery Systems Market

22.1. Russia Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Novel Drug Delivery Systems Market

23.1. North America Novel Drug Delivery Systems Market Overview
23.2. North America Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Novel Drug Delivery Systems Market

24.1. USA Novel Drug Delivery Systems Market Overview
24.2. USA Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Novel Drug Delivery Systems Market

25.1. Canada Novel Drug Delivery Systems Market Overview
25.2. Canada Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Novel Drug Delivery Systems Market

26.1. South America Novel Drug Delivery Systems Market Overview
26.2. South America Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Novel Drug Delivery Systems Market

27.1. Brazil Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Novel Drug Delivery Systems Market

28.1. Middle East Novel Drug Delivery Systems Market Overview
28.2. Middle East Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Novel Drug Delivery Systems Market

29.1. Africa Novel Drug Delivery Systems Market Overview
29.2. Africa Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Novel Drug Delivery Systems Market Competitive Landscape And Company Profiles

30.1. Novel Drug Delivery Systems Market Competitive Landscape
30.2. Novel Drug Delivery Systems Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Novel Drug Delivery Systems Market Other Major And Innovative Companies

31.1. Bayer AG
31.2. Sanofi SA
31.3. Bristol-Myers Squibb Company
31.4. Thermo Fisher Scientific Company
31.5. AstraZeneca PLC
31.6. Abbott Laboratories
31.7. Novartis AG
31.8. GlaxoSmithKline PLC (GSK)
31.9. Takeda Pharmaceutical Company Limited
31.10. Eli Lilly and Company
31.11. Gilead Sciences
31.12. Amgen Inc.
31.13. Teva Pharmaceutical Industries Ltd.
31.14. Otsuka Pharmaceutical Co. Ltd.
31.15. Boston Scientific Corporation

32. Global Novel Drug Delivery Systems Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Novel Drug Delivery Systems Market

34. Recent Developments In The Novel Drug Delivery Systems Market

35. Novel Drug Delivery Systems Market High Potential Countries, Segments and Strategies

35.1 Novel Drug Delivery Systems Market In 2029 - Countries Offering Most New Opportunities
35.2 Novel Drug Delivery Systems Market In 2029 - Segments Offering Most New Opportunities
35.3 Novel Drug Delivery Systems Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer